Idéal Investisseur
Français English
CAC 40 :
8 157,82 pts
-0.84%


Last updated : 24/04/2026 - 17h35 (last close)
Last close data
🏠 Home   ➤    Stock news

Eurofins Scientific Stock: Over 2% Rebound After a Week of Decline

Eurofins Scientific stock is showing signs of recovery this Friday, February 13, with a 2.09% increase to 65.36 euros after several consecutive sessions of decline. This rebound occurs in a technically tense context, with the stock having lost nearly 4.5% over the past seven days. However, its annual performance remains solidly positive, at nearly 30%.


Eurofins Scientific Stock: Over 2% Rebound After a Week of Decline

Current Trading Position

Eurofins Scientific's share price is currently at 65.36 euros, just above its 50-day moving average of 65.12 euros, a level that the stock briefly dipped below in recent sessions. If this upward crossing is confirmed at the close, it could represent a short-term stabilization point. The RSI indicator is at 24, well below the usual oversold threshold of 30, indicating a recent bearish excess and signaling that selling pressure has been particularly intense in recent sessions. The most relevant technical support is at 62.00 euros, a floor that was not tested during the recent correction, as the stock found a low near its 200-day moving average of 62.27 euros.

Overall Dynamics

Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
Before 9 AM every morning Euronext data AI-powered analysis

Despite the weekly decline, the overall momentum of the bioanalysis specialist remains positive. Over three months, the stock has gained 10.07%, while the annual performance reaches 29.48%. This trajectory reflects the progressive revaluation of the group, whose course has moved significantly away from its 200-day moving average, established at 62.27 euros. The monthly volatility, measured at 9%, remains contained for a stock in this segment, suggesting that recent movements are within usual ranges. The extremely low beta, at 0.02, further confirms the stock's low correlation with general market fluctuations. Today's rebound brings the price back to the lower part of the Bollinger bands, with the lower boundary at 64.31 euros, which served as a support zone in the previous session. The major resistance to watch is positioned at 73.12 euros, nearly 12% away from the current price.



Sector Santé · Pharmacie Services médicaux


Assurance vie

Context

Period
  • Period: 2025
Key reported figures
  • Revenue: 7 296 M€
  • Revenue growth: 5,0%
  • EBITDA: 1 561 M€
  • EBITDA margin: 21,4%
  • Net income: 473 M€
  • Free cash flow: 876 M€
  • Net debt: 3 641 M€
  • Dividend per share: 0,72 €
Guidance from the release
  • Nous sommes satisfaits d’avoir atteint nos objectifs 2025 et de démontrer la solidité du portfolio Eurofins.
  • La performance 2025 est soutenue par la croissance organique et l’expansion des marges, avec un flux de trésorerie libre robuste et un endettement maîtrisé.

The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.

Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.

Advertisement
Every morning
Technical market signals,
before the opening bell.
CAC 40 · SBF 120 · Signals · Analysts
🤖
Today's edition — pre-market
CAC 40
7 702
-0,87%
SBF 120
5 827
-0,87%
📈 Bullish signals
+5,2%
+1,8%
+0,9%
📉 Bearish signals
-14%
-5,7%
🔄 Analyst opinions
▲ 35 €
▼ 80 €
Sign up to see everything →
Before 9 AM every morning
Euronext data
AI-powered analysis





BOURSE · Chaque matin
La synthèse bourse,
avant l'ouverture.
Notre moteur analyse chaque nuit le CAC 40 et le SBF 120. Ce qui mérite attention remonte directement dans votre boîte mail. Gratuit.
Avant 9h00 1000+ inscrits 100% gratuit